Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 2/20 | 0.54 |
| ▸ | LTA4H | P09960 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | RARA | P10276 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21834924 | 0.95 | LTA4H (0.56) | LTA4HTSHRRECQLDGKAL3MBTL1 | |
| SCHEMBL11609208 | 0.94 | DGKA (0.60) | RARBLTA4HTSHRDGKASMN1; SMN2 | |
| SCHEMBL11610383 | 0.94 | DGKA (0.60) | RARBLTA4HTSHRDGKASMN1; SMN2 | |
| SCHEMBL5973017 | 0.94 | DGKA (0.60) | RARBLTA4HTSHRDGKASMN1; SMN2 | |
| SCHEMBL3228372 | 0.91 | DGKA (0.62) | LTA4HTSHRDGKATDP1THRB | |
| SCHEMBL28497676 | 0.91 | THRB (0.51) | RARBLTA4HTSHRRECQLL3MBTL1 | |
| SCHEMBL14491646 | 0.91 | THRB (0.54) | TSHRL3MBTL1TDP1THRBSMN1; SMN2 | |
| SCHEMBL11713345 | 0.89 | DGKA (0.66) | LTA4HTSHRDGKA | |
| SCHEMBL5354673 | 0.89 | DGKA (0.66) | LTA4HTSHRDGKA | |
| SCHEMBL5350282 | 0.89 | DGKA (0.66) | LTA4HTSHRDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113636932-A | Method for manufacturing low VOC coalescing aids | 陶氏环球技术有限责任公司 | 2021-11-12 | — | — | CN | disclosed |
| EP-3160931-B1 | PROCESS FOR PRODUCING LOW VOC COALESCING AIDS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-11-14 | — | — | EP | disclosed |
| US-9908839-B2 | Process for producing low VOC coalescing aids | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-03-06 | — | — | US | disclosed |
| EP-3160931-A1 | PROCESS FOR PRODUCING LOW VOC COALESCING AIDS | Dow Global Technologies LLC (US) | 2017-05-03 | — | — | EP | disclosed |
| US-20170113997-A1 | PROCESS FOR PRODUCING LOW VOC COALESCING AIDS | DOW GLOBAL TECHNOLOGIES LLC | 2017-04-27 | — | — | US | disclosed |
| WO-2015200088-A1 | PROCESS FOR PRODUCING LOW VOC COALESCING AIDS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170113997-A1 | PROCESS FOR PRODUCING LOW VOC COALESCING AIDS | MVD, GGPS1, PAICS | RARB 309/4885LTA4H 538/4885TSHR 4861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.